Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Cañizo-Gómez FJD. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes 2014; 5(4): 444-470 [PMID: 25126392 DOI: 10.4239/wjd.v5.i4.444]
Corresponding Author of This Article
Dr. Francisco Javier del Cañizo Gómez, Professor of Medicine, Chief of Endocrinology Section, Hospital Universitario Infanta Leonor, Facultad de Medicina, Universidad Complutense, Avda Gran Vía del Este 80, Madrid 28031, Spain. fjcanizog@salud.madrid.org
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Aug 15, 2014; 5(4): 444-470 Published online Aug 15, 2014. doi: 10.4239/wjd.v5.i4.444
Table 1 Cardiovascular risk factors in diabetes mellitus
Traditional
Nontraditional
Dyslipidaemia
Insulin resistance and Hyperinsulinemia
Hypertension
Postprandial Hyperglycaemia
Obesity
Glucose variability
Abdominal obesity
Microalbuminuria
Physical exercise
Haematological factors
Cigarette smoking
Thrombogenic factors
Inflammation C-reactive protein
Homocysteine and vitamins
Erectile dysfunction
Genetics and Epigenetics
Table 2 Recommendations for blood pressure control in diabetes
Recommendations
Class
Level
Blood pressure control is recommended in patients with diabetes mellitus and hypertension to lower the risk of cardiovascular events
I
A
It is recommended that a patient with hypertension and diabetes mellitus is treated in an individualized manner, targeting a blood pressure of < 140/85 mmHg
I
A
It is recommended that a combination of blood pressure lowering agents is used to achieve blood pressure control
I
A
A RAAS blocker (ACE-I or ARB) is recommended in the treatment of hypertension in diabetes mellitus, particularly in the presence of proteinuria or microalbuminuria
I
A
Simultaneous administration of two RAAS blockers should be avoided in patients with diabetes mellitus
III
B
Table 3 Suggested mechanisms for the influence of smoking on risk of type 2 diabetes
Direct effects due to inhalation of smoke from tobacco products
Impaired insulin sensitivity based on influence of haemodynamic dysregulation in capillary vascular bed
Impaired insulin sensitivity due to increase in inflammatory markers secondary to bronchitis and pulmonary infections caused by smoking
Impaired beta-cell function due to toxic effects of tobacco smoke
Lipotoxicity due to influence of increased triglyceride levels
Hypercortisolaemia and increase in abdominal fat tissue
Elevated sympathetic nervous activation
Indirect effects on glucose metabolism
Unhealthy lifestyle in smokers (poor diet, lack of physical activity)
Increased alcohol consumption (toxic effects on beta cells)
Psychosocial stress and impaired sleep associated with smoking
Impaired fetal growth in smoking pregnant women, associated with increased diabetes risk in offspring in adult life
Table 4 The strategic “five As” for smoking cessation
A-ASK:
Systematically inquire about smoking status at every opportunity
A-ADVISE:
Unequivocally urge all smokers to quit
A-ASSESS:
Determine the person’s degree of addiction and readiness to quit
A-ASSIST
Agree on a smoking cessation strategy, including setting a quit date, behavioral counseling, and pharmacological support
A-ARRANGE
Arrange a schedule for follow-up
Citation: Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Cañizo-Gómez FJD. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes 2014; 5(4): 444-470